EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 7 July 2022

EU pharma in numbers: a portrait of an industry at a crossroads

Learn more

"The Pharmaceutical Industry in Figures report is a snapshot in time. It tells us where we are today but says nothing about the future. (...) The information contained in the 2022 report, together with trend data over recent years and international comparison data can be used to inform the urgent discussions we need to have about Europe’s place in a competitive world and how pharma can contribute both to health and wealth in a key moment for policy development on the continent" says Nathalie Moll, EFPIA Director General.

Read more

News

EFPIA statement on European Council decision on membership applications from Ukraine and Moldova...
24 June 2022

Read more

Blogs

Improving sustainable patient access to oncology combination therapies in Europe: a trade association...
01 July 2022 - Veronica Calzada

Challenges that can be solved if shared by all stakeholders Read more

#WeWontRest until patients everywhere can see the results of innovation in black and white
29 June 2022 - Andy Powrie-Smith

Innovation is not an abstract concept, it transforms the lives of patients. It means new experiences, moments shared... Read more

Landmark moment for the Innovative Health Initiative (IHI)
28 June 2022 - Magda Chlebus

IHI’s first calls for proposals present an unprecedented opportunity to tackle key EU priorities and unmet medical need... Read more

#WeWontRest until patients everywhere can see the results of innovation, in black and white

What we are reading

Supporting patients in a war zone
On 30 June 2022 (GOLD)

How has the pharmaceutical industry and its relevant organisations responded to create healthcare continuity and prevent... Read more

The research-based pharmaceutical industry has a vision for a healthier future for Europe.
On 24 June 2022 (Lilly)

By Nathalie Moll, EFPIA Director General. Read more

Europe faces choice between innovation or the risk of stagnation, writes Bernard Mallee
On 22 June 2022 (IPHA)

A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu